ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Therapix, University of Calgary to Evaluate Proprietary Drug Candidate for Pain
December 24, 2020Therapix Biosciences announced a collaboration between the company and The University of Calgary to further evaluate the analgesic effect of Therapix's CB2R agonist proprietary drug candidate, THX-160. -
Therapix Biosciences Announces Continued Development of Autism Spectrum Disorder Treatment
December 30, 2019Therapix Biosciences has announced the progression of its RESPECTRUM product candidate into clinical stage. The company plans to initiate a randomized ...
Pharma Sources Insight January 2025
